Amyloid-directed monoclonal antibodies for the treatment of Alzheimer’s disease: the point of no return?
Year: 2014
Type: review
Institutions: University of Bari Aldo Moro, Chiesi (Italy)
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2149227806
